| Kaysea Nunez, | |
|
706 Goodyear Blvd, Picayune, MS 39466-3220 | |
| (601) 798-3230 | |
| Not Available |
| Full Name | Kaysea Nunez |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 706 Goodyear Blvd, Picayune, Mississippi |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457676082 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 127637 (Mississippi) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kaysea Nunez, 706 Goodyear Blvd, Picayune, MS 39466-3220 Ph: (601) 798-3230 | Kaysea Nunez, 706 Goodyear Blvd, Picayune, MS 39466-3220 Ph: (601) 798-3230 |
News Archive
How do you annihilate lymphoma without using any drugs? Starve it to death by depriving it of what appears to be a favorite food: HDL cholesterol.
Humacyte, Inc. and Xcellerex, Inc. have entered into an initial strategic collaboration for Xcellerex to develop a novel manufacturing process that will enable the production of Humacyte's lead regenerative medicine product using Xcellerex's XDR single use bioreactor system in its FlexFactory®. Humacyte's product is a large diameter vascular graft that is based on its innovative and proprietary platform technology for engineering human, extracellular matrix-based tissues that have properties that are similar to native tissues.
Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Carbidopa and Levodopa Tablets USP, 10mg/100mg, 25mg/100mg and 25mg/250 mg.
New research by a team of scientists at The Hong Kong University of Science and Technology sheds light on the epitopic targets of SARS-CoV-2 by T cells in COVID-19 convalescents. The team's findings suggest that the epitopes targeted by T cells during infection may not be affected by the emergence of SARS-CoV-2 variants.
Researchers at the University of Texas Medical Branch at Galveston have been awarded an $11.3 Million, multi-year grant from the National Institute of Allergy and Infectious Diseases to study immunopathogenesis of Ebola, and in particular to determine why cells infected with Ebola develop "immune system paralysis," which inhibits immune response, leads to hyperinflammation, and allows the deadly infection to spread.
› Verified 2 days ago
Gabrielle I Scott, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1620 Highway 11 N Ste C, Picayune, MS 39466 Phone: 769-242-2626 Fax: 769-242-2685 | |
Communication Connection, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 117b N Main St, Picayune, MS 39466 Phone: 601-798-6900 Fax: 601-798-6975 | |
Mrs. Stephanie Deanne Farrell, SPEECH PATHOLOGIST Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 201 E. Second Street, Picayune, MS 39466 Phone: 601-799-4065 Fax: 601-799-4064 | |
Lambert Therapy Services Of Picayune, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 317 N Main St, Picayune, MS 39466 Phone: 769-926-2441 Fax: 769-926-2442 | |
Kavonna Bradley, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 317 N Main St, Picayune, MS 39466 Phone: 769-926-2441 | |
Casey Bauer, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 117b N Main St, Picayune, MS 39466 Phone: 601-889-9800 Fax: 601-889-9885 | |
Tots To Teens Communication Therapy, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 117b N Main St, Picayune, MS 39466 Phone: 601-889-9800 Fax: 601-889-9885 |